D-Allulose Improves Fructose-Induced Skeletal Muscle Insulin Resistance via Ectopic Modulation

Why this paper matters

Fructose is still a workhorse sweetener. But pair it with a high-fat diet and the metabolic bill comes due in skeletal muscle. That’s the problem the authors set out to fix. Their paper, published in Nutrients (2025, 17, 2050; DOI: 10.3390/nu17122050), tested whether D-allulose could blunt the damage.

The background

Sweetened beverages plus high-fat diets are a known driver of obesity, diabetes, and metabolic dysfunction-associated steatotic liver disease. Less obvious is the effect on muscle. When muscle accumulates fat outside adipose tissue, insulin signaling suffers. This “ectopic” lipid burden is one of the reasons insulin resistance develops. The researchers asked whether allulose, a low-calorie sugar epimer, could reduce that muscle fat and restore insulin action.

What the study did

The team used a high-fat plus fructose (HFF) model. That’s a deliberate double hit: high fat promotes ectopic storage, and fructose in the drinking water mimics the way many consumers take added sugar. Against that background, they gave D-allulose and looked at insulin resistance, triglyceride levels in blood, liver, and muscle, and specific phosphorylation steps in the insulin signaling cascade.

What the findings show

Allulose supplementation improved insulin resistance in the HFF group. It also cut triglycerides in all three measured compartments: blood, liver, and skeletal muscle. In muscle, insulin-stimulated AKT phosphorylation went up. So did phosphorylation of acetyl-CoA carboxylase. That second marker matters because ACC sits at a control point between lipid storage and oxidation.

The authors’ interpretation is direct: allulose may improve insulin resistance by lowering triglyceride accumulation in skeletal muscle, and this effect may be independent of its anti-obesity properties.

Parameter	HFF group	HFF plus allulose
Insulin resistance	Present	Improved
Blood triglycerides	Higher	Lowered
Liver triglycerides	Higher	Lowered
Skeletal muscle triglycerides	Higher	Lowered
Muscle AKT phosphorylation	Lower	Enhanced
Muscle ACC phosphorylation	Lower	Enhanced

What this means for formulators

If you sell a beverage that contains fructose, this paper gives you a reason to look at the sweetener matrix. Allulose doesn’t just replace bulk sweetness. It may modulate metabolic outcomes in muscle, even when the diet is already pushing toward dysfunction. That is a different value proposition from zero-calorie sweetness. For ingredient buyers, the message is about positioning: allulose can be part of a formulation aimed at metabolic health, not just sugar reduction.

This is early-stage work. The study is mechanistic, and the human translation needs more data. But the mechanism has a clear target: ectopic triglyceride in muscle. If allulose lowers that pool and restores insulin-stimulated phosphorylation, it becomes relevant for products marketed to people managing blood sugar or metabolic health.

Questions manufacturers ask

Does allulose work only because it reduces body weight?
The paper says no. The researchers concluded the muscle effect may be independent of anti-obesity properties. That’s a meaningful distinction for formulators.

Is this only about high-fat diets?
The study used a high-fat plus fructose model, so the direct application is to a worst-case dietary context. But the outcome—lower muscle fat, better insulin signaling—is generalizable enough to warrant further product-level research.

What should you watch for?
Look for follow-up studies that confirm these phosphorylation changes in human muscle. Until then, the science supports allulose as a functional carbohydrate, not just a sweetener.

The practical picture

The evidence here is clean. Allulose improved insulin resistance and reduced triglycerides in blood, liver, and muscle. It also raised phosphorylation of AKT and ACC in skeletal muscle, two markers directly tied to insulin action and fat metabolism. For formulators, the practical point is simple: the sweetener you choose can change more than taste. Allulose appears to act on ectopic lipid metabolism, and that deserves a closer look in product development.